Cargando…
Low-grade central fibroblastic osteosarcoma may be differentiated from its mimicker desmoplastic fibroma by genetic analysis
BACKGROUND: We studied two cases of rare fibrous bone tumors, namely desmoplastic fibroma (DF) and low-grade central osteosarcoma (LGCOS) resembling desmoplastic fibroma (DF-like LGCOS). As the clinical presentation, imaging features and histopathology of DF and DF-like LGOS show much overlap, the o...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106748/ https://www.ncbi.nlm.nih.gov/pubmed/30159138 http://dx.doi.org/10.1186/s13569-018-0104-z |
_version_ | 1783349839783788544 |
---|---|
author | Song, Wangzhao van den Berg, Eva Kwee, Thomas C. Jutte, Paul C. Cleton-Jansen, Anne-Marie Bovée, Judith V. M. G. Suurmeijer, Albert J. |
author_facet | Song, Wangzhao van den Berg, Eva Kwee, Thomas C. Jutte, Paul C. Cleton-Jansen, Anne-Marie Bovée, Judith V. M. G. Suurmeijer, Albert J. |
author_sort | Song, Wangzhao |
collection | PubMed |
description | BACKGROUND: We studied two cases of rare fibrous bone tumors, namely desmoplastic fibroma (DF) and low-grade central osteosarcoma (LGCOS) resembling desmoplastic fibroma (DF-like LGCOS). As the clinical presentation, imaging features and histopathology of DF and DF-like LGOS show much overlap, the objective of this study was to investigate the value of cytogenetic analysis, molecular pathology and immunohistochemistry in discrimination of these two mimickers. CASE PRESENTATION: A mutation in CTNNB (S45F) and nuclear beta-catenin immunostaining were observed in DF. DF-LGCOS had amplification of CDK4 and showed strong nuclear expression of CDK4 by IHC. Moreover, the karyotype of DF-LGCOS showed an interstitial heterozygous deletion of the long arm of chromosome 13 (q12q32), associated with loss of the RB1 tumor suppressor gene. CONCLUSIONS: Karyotyping and molecular genetic analysis may contribute to a conclusive diagnosis. |
format | Online Article Text |
id | pubmed-6106748 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-61067482018-08-29 Low-grade central fibroblastic osteosarcoma may be differentiated from its mimicker desmoplastic fibroma by genetic analysis Song, Wangzhao van den Berg, Eva Kwee, Thomas C. Jutte, Paul C. Cleton-Jansen, Anne-Marie Bovée, Judith V. M. G. Suurmeijer, Albert J. Clin Sarcoma Res Case Report BACKGROUND: We studied two cases of rare fibrous bone tumors, namely desmoplastic fibroma (DF) and low-grade central osteosarcoma (LGCOS) resembling desmoplastic fibroma (DF-like LGCOS). As the clinical presentation, imaging features and histopathology of DF and DF-like LGOS show much overlap, the objective of this study was to investigate the value of cytogenetic analysis, molecular pathology and immunohistochemistry in discrimination of these two mimickers. CASE PRESENTATION: A mutation in CTNNB (S45F) and nuclear beta-catenin immunostaining were observed in DF. DF-LGCOS had amplification of CDK4 and showed strong nuclear expression of CDK4 by IHC. Moreover, the karyotype of DF-LGCOS showed an interstitial heterozygous deletion of the long arm of chromosome 13 (q12q32), associated with loss of the RB1 tumor suppressor gene. CONCLUSIONS: Karyotyping and molecular genetic analysis may contribute to a conclusive diagnosis. BioMed Central 2018-08-23 /pmc/articles/PMC6106748/ /pubmed/30159138 http://dx.doi.org/10.1186/s13569-018-0104-z Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Case Report Song, Wangzhao van den Berg, Eva Kwee, Thomas C. Jutte, Paul C. Cleton-Jansen, Anne-Marie Bovée, Judith V. M. G. Suurmeijer, Albert J. Low-grade central fibroblastic osteosarcoma may be differentiated from its mimicker desmoplastic fibroma by genetic analysis |
title | Low-grade central fibroblastic osteosarcoma may be differentiated from its mimicker desmoplastic fibroma by genetic analysis |
title_full | Low-grade central fibroblastic osteosarcoma may be differentiated from its mimicker desmoplastic fibroma by genetic analysis |
title_fullStr | Low-grade central fibroblastic osteosarcoma may be differentiated from its mimicker desmoplastic fibroma by genetic analysis |
title_full_unstemmed | Low-grade central fibroblastic osteosarcoma may be differentiated from its mimicker desmoplastic fibroma by genetic analysis |
title_short | Low-grade central fibroblastic osteosarcoma may be differentiated from its mimicker desmoplastic fibroma by genetic analysis |
title_sort | low-grade central fibroblastic osteosarcoma may be differentiated from its mimicker desmoplastic fibroma by genetic analysis |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6106748/ https://www.ncbi.nlm.nih.gov/pubmed/30159138 http://dx.doi.org/10.1186/s13569-018-0104-z |
work_keys_str_mv | AT songwangzhao lowgradecentralfibroblasticosteosarcomamaybedifferentiatedfromitsmimickerdesmoplasticfibromabygeneticanalysis AT vandenbergeva lowgradecentralfibroblasticosteosarcomamaybedifferentiatedfromitsmimickerdesmoplasticfibromabygeneticanalysis AT kweethomasc lowgradecentralfibroblasticosteosarcomamaybedifferentiatedfromitsmimickerdesmoplasticfibromabygeneticanalysis AT juttepaulc lowgradecentralfibroblasticosteosarcomamaybedifferentiatedfromitsmimickerdesmoplasticfibromabygeneticanalysis AT cletonjansenannemarie lowgradecentralfibroblasticosteosarcomamaybedifferentiatedfromitsmimickerdesmoplasticfibromabygeneticanalysis AT boveejudithvmg lowgradecentralfibroblasticosteosarcomamaybedifferentiatedfromitsmimickerdesmoplasticfibromabygeneticanalysis AT suurmeijeralbertj lowgradecentralfibroblasticosteosarcomamaybedifferentiatedfromitsmimickerdesmoplasticfibromabygeneticanalysis |